Nicotinic acetylcholine receptor activation reduces skeletal muscle inflammation of mdx mice

Journal of Neuroimmunology

Volumn 227, Issue 1-2, 2010, Pages 44-51

  Leite, Paulo Emílio Corrêa ^a,b   Lagrota Candido, Jussara ^a   Moraes, Louise ^b   D'Elia, Livia ^b   Pinheiro, Douglas Florindo ^a   da Silva, Rafael Ferreira ^a   Yamasaki, Edna N ^b   Quirico Santos, Thereza ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Acetylcholine receptor; Cytokine; Macrophage; Mdx; Muscular dystrophy; Skeletal muscle

Indexed keywords

COLLAGEN; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MYOGENIN; NICOTINE; NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA7; NICOTINIC AGENT; NICOTINIC RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; BUNGAROTOXIN RECEPTOR; CHRNA7 PROTEIN, MOUSE; PROTEIN SUBUNIT;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; DUCHENNE MUSCULAR DYSTROPHY; ENZYME INHIBITION; GENE EXPRESSION; IN VIVO STUDY; INFLAMMATORY INFILTRATE; MACROPHAGE; MALE; MOUSE; MUSCLE NECROSIS; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SKELETAL MUSCLE; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; IMMUNOLOGY; METABOLISM; MUSCULAR DYSTROPHY, DUCHENNE; MYOSITIS; NECROSIS; PATHOLOGY; PHYSIOLOGY; PROTEIN SUBUNIT; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; MYOSITIS; NECROSIS; PROTEIN SUBUNITS; RECEPTORS, NICOTINIC; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR;

EID: 77956648881     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.06.005     Document Type: Article

References (43)

1. Bani C., Lagrota-Candido J., Pinheiro D.F., Leite P.E., Salimena M.C., Henriques-Pons A., Quirico-Santos T. Pattern of metalloprotease activity and myofiber regeneration in skeletal muscles of mdx mice. Muscle Nerve 2008, 37:583-592.
2. Bernik T.R., Friedman S.G., Ochani M., DiRaimo R., Ulloa L., Yang H., Sudan S., Czura C.J., Ivanova S.M., Tracey K.J. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J. Exp. Med. 2002, 195:781-788.
3. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., Wang H., Abumrad N., Eaton J.W., Tracey K.J. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405:458-462.
4. Carlson C.G. The dystrophinopathies: an alternative to structural hypothesis. Neurobiol. Dis. 1998, 5:3-15.
5. Domonkos A., Udvardy A., Laszlo L., Nagy T., Duda E. Receptor-like properties of the 26kDa transmembrane form of TNF. Eur. Cytokine Netw. 2001, 12:411-419.
6. Evans N.P., Misyak S.A., Robertson J.L., Bassaganya-Riera J., Grange R.W. Immune-mediated mechanisms potentially regulate the disease time-course of Duchenne muscular dystrophy and provide targets for therapeutic intervention. PMR 2009, 1:755-768.
7. Gotti C., Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog. Neurobiol. 2004, 74:363-396.
8. Grounds M.D., Torrisi J. Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis. FASEB J. 2004, 18:676-682.
9. Guttridge D.C., Mayo M.W., Madrid L.V., Wang C.Y., Baldwin A.S. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000, 289:2363-2366.
10. Heussen C., Dowdle E.B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 1980, 102:196-202.
11. Hodgetts S., Radley H., Davies M., Grounds M.D. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice. Neuromuscul. Disord. 2006, 16:591-602.
12. Kawashima K., Fujii T. The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci. 2003, 74:675-696.
13. Khazen W., M'Bika J.P., Tomkiewicz C., Benelli C., Chany C., Achour A., Forest C. Expression of macrophage-selective markers in human and rodent adipocytes. FEBS Lett. 2005, 579:5631-5634.
14. Kherif S., Lafuma C., Dehaupas M., Lachkar S., Fournier J.G., Verdiere-Sahuque M., Fardeau M., Alameddine H.S. Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles. Dev. Biol. 1999, 205:158-170.
15. Lagrota-Candido J., Vasconcellos R., Cavalcanti M., Bozza M., Savino W.Q., Quirico-Santos T. Resolution of skeletal muscle inflammation in mdx dystrophic mouse is accompanied by increased immunoglobulin and interferon-g production. Intern. J. Exp. Pathol. 2002, 83:121-132.
16. Lefaucher J.P., Sebille A. Features of dystrophy in smooth and skeletal muscles of mdx mice. Muscle Nerve 1996, 793-794.
17. Li H., Mittal A., Makonchuk D.Y., Bhatnagar S., Kumar A. Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy. Hum. Mol. Genet. 2009, 18:2584-2598.
18. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
19. McGeachie J.K., Grounds M.D. The timing between skeletal muscle myoblast replication and fusion into myotubes, and the stability of regenerated dystrophic myofibres: an autoradiographic study in mdx mice. J. Anat. 1999, 194:287-295.
20. Messina S., Bitto A., Aguennouz M., Minutoli L., Monici M.C., Altavilla D., Squadrito F., Vita G. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in mdx mice. Exp. Neurol. 2006, 198:234-241.
21. Mullberg J., Althoff K., Jostock T., Rose-John S. The importance of shedding of membrane proteins for cytokine biology. Eur. Cytokine Netw. 2000, 11:27-38.
22. Nizri E., Hamra-Amitay Y., Sicsic C., Lavon I., Brenner T. Anti-inflammatory properties of cholinergic up-regulation: a new role for acetylcholinesterase inhibitors. Neuropharmacology 2006, 50:540-547.
23. Osborne-Hereford A.V., Rogers S.W., Gahring L.C. Neuronal nicotinic alpha7 receptors modulate inflammatory cytokine production in the skin following ultraviolet radiation. J. Neuroimmunol. 2008, 193:130-139.
24. Pavlov V.A., Tracey K.J. The cholinergic anti-inflammatory pathway. Brain Behav. Immun. 2005, 19:493-499.
25. Pavlov V.A., Tracey K.J. Controlling inflammation: the cholinergic anti-inflammatory pathway. Biochem. Soc. Trans. 2006, 34:1037-1040.
26. Rendon-Mitchell B., Ochani M., Li J., Han J., Wang H., Yang H., Susarla S., Czura C., Mitchell R.A., Chen G., Sama A.E., Tracey K.J. IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J. Immunol. 2003, 170:3890-3897.
27. Rosas-Ballina M., Goldstein R.S., Gallowitsch-Puerta M., Yang L., Valdes-Ferrer S.I., Patel N.B., Chavan S., Al-Abed Y., Yang H., Tracey K.J. The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE. Mol. Med. 2009, 15:195-202.
28. Rosas-Ballina M., Ochani M., Parrish W.R., Ochani K., Harris Y.T., Huston J.M., Chavan S., Tracey K.J. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc. Nat. Acad. Sci. U.S.A. 2008, 105:11008-11013.
29. Saeed R.W., Varma S., Peng-Nemeroff T., Sherry B., Balakhaneh D., Huston J., Tracey K.J., Al-Abed Y., Metz C.N. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J. Exp. Med. 2005, 201:1113-1123.
30. Shytle R.D., Mori T., Townsend K., Vendrame M., Sun N., Zeng J., Ehrhart J., Silver A.A., Sanberg P.R., Tan J. Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J. Neurochem. 2004, 89:337-343.
31. Talhouk R.S., Bissell M.J., Werb Z. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J. Cell Biol. 1992, 118:1271-1282.
32. Tayebati S.K., Amenta F., El-Assouad D., Zaccheo D. Muscarinic cholinergic receptor subtypes in the hippocampus of aged rats. Mech. Ageing Dev. 2002, 123:521-528.
33. Torres L.F., Duchen L.W. The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates. Brain 1987, 110(Pt 2):269-299.
34. Tracey K.J. The inflammatory reflex. Nature 2002, 420:853-859.
35. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest. 2007, 117:289-296.
36. Ulloa L. The vagus nerve and the nicotinic anti-inflammatory pathway. Nat. Rev. Drug Discov. 2005, 4:673-684.
37. van Maanen M.A., Lebre M.C., van der Poll T., LaRosa G.J., Elbaum D., Vervoordeldonk M.J., Tak P.P. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum. 2009, 60:114-122.
38. van Westerloo D.J., Giebelen I.A., Florquin S., Daalhuisen J., Bruno M.J., de Vos A.F., Tracey K.J., van der Poll T. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J. Infect. Dis. 2005, 191:2138-2148.
39. Voisin V., de la Porte S. Therapeutic strategies for Duchenne and Becker dystrophies. Int. Rev. Cytol. 2004, 240:1-30.
40. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Yang H., Ulloa L., Al-Abed Y., Czura C.J., Tracey K.J. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003, 421:384-388.
41. Williams S., Jacobson C. Alpha-dystroglycan is essential for the induction of Egr3, a transcription factor important in muscle spindle formation. Dev. Neurobiol. 2010, 70(7):498-507.
42. Xin L., Wang J., Zhang H., Shi W., Yu M., Li Q., Jiang X., Gong F., Gardner K., Li Q.Q., Li Z. Dual regulation of soluble tumor necrosis factor-alpha induced activation of human monocytic cells via modulating transmembrane TNF-alpha-mediated 'reverse signaling'. Int. J. Mol. Med. 2006, 18:885-892.
43. Yoshikawa H., Kurokawa M., Ozaki N., Nara K., Atou K., Takada E., Kamochi H., Suzuki N. Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin. Exp. Immunol. 2006, 146:116-123.